These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11698309)

  • 21. Effect of influenza virus vaccine on the expression of human immunodeficiency virus co-receptor CCR5.
    Rucker RP; Day NK; Good RA; Kamchaisatian W; Emmanuel P; Sleasman JW; Mayeski C; Dinglasan E; Haraguchi S; Tangsinmankong N
    Ann Allergy Asthma Immunol; 2004 Sep; 93(3):272-6. PubMed ID: 15478388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Markers of lymphocyte homing distinguish CD4 T cell subsets that turn over in response to HIV-1 infection in humans.
    Hengel RL; Jones BM; Kennedy MS; Hubbard MR; McDougal JS
    J Immunol; 1999 Sep; 163(6):3539-48. PubMed ID: 10477629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD25+ FoxP3+ Memory CD4 T Cells Are Frequent Targets of HIV Infection In Vivo.
    Chachage M; Pollakis G; Kuffour EO; Haase K; Bauer A; Nadai Y; Podola L; Clowes P; Schiemann M; Henkel L; Hoffmann D; Joseph S; Bhuju S; Maboko L; Sarfo FS; Eberhardt K; Hoelscher M; Feldt T; Saathoff E; Geldmacher C
    J Virol; 2016 Oct; 90(20):8954-67. PubMed ID: 27384654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered CD4+ T cell homing to the gut impairs mucosal immune reconstitution in treated HIV-infected individuals.
    Mavigner M; Cazabat M; Dubois M; L'Faqihi FE; Requena M; Pasquier C; Klopp P; Amar J; Alric L; Barange K; Vinel JP; Marchou B; Massip P; Izopet J; Delobel P
    J Clin Invest; 2012 Jan; 122(1):62-9. PubMed ID: 22156200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential susceptibility of resting CD4(+) T lymphocytes to a T-tropic and a macrophage (M)-tropic human immunodeficiency virus type 1 is associated with their surface expression of CD38 molecules.
    Horikoshi H; Kinomoto M; Sasao F; Mukai T; Luftig RB; Ikuta K
    Virus Res; 2001 Jan; 73(1):1-16. PubMed ID: 11163640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of human immunodeficiency virus type 1 infection on CCR5 and CXCR4 coreceptor expression on CD4 T lymphocyte subsets in infants and adolescents.
    Tuttle DL; Coberley CR; Xie X; Kou ZC; Sleasman JW; Goodenow MM
    AIDS Res Hum Retroviruses; 2004 Mar; 20(3):305-13. PubMed ID: 15117454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ontogeny of CD4+ T Lymphocytes With Phenotypic Susceptibility to HIV-1 During Exclusive and Nonexclusive Breastfeeding in HIV-1-Exposed Ugandan Infants.
    McFarland EJ; Powell TM; Onyango-Makumbi C; Zhang W; Melander K; Naluyima P; Okurut S; Eller MA; Fowler MG; Janoff EN
    J Infect Dis; 2017 Feb; 215(3):368-377. PubMed ID: 27932619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of highly active antiretroviral treatment on expression of HIV-1 coreceptors and ligand levels in peripheral blood from HIV-1 infected patients in China.
    Fang J; Bai S; Wu L; Zhu X; Yao X; Jin C; Wang C
    J Int Med Res; 2013 Oct; 41(5):1560-9. PubMed ID: 24043708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The integrin alpha4beta7 forms a complex with cell-surface CD4 and defines a T-cell subset that is highly susceptible to infection by HIV-1.
    Cicala C; Martinelli E; McNally JP; Goode DJ; Gopaul R; Hiatt J; Jelicic K; Kottilil S; Macleod K; O'Shea A; Patel N; Van Ryk D; Wei D; Pascuccio M; Yi L; McKinnon L; Izulla P; Kimani J; Kaul R; Fauci AS; Arthos J
    Proc Natl Acad Sci U S A; 2009 Dec; 106(49):20877-82. PubMed ID: 19933330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mapping the extent of heterogeneity of human CCR5+ CD4+ T cells in peripheral blood and lymph nodes.
    Zaunders J; Munier CML; McGuire HM; Law H; Howe A; Xu Y; de St Groth BF; Schofield P; Christ D; Milner B; Obeid S; Dyer WB; Saksena NK; Kelleher AD
    AIDS; 2020 May; 34(6):833-848. PubMed ID: 32044843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrin α
    Sivro A; Schuetz A; Sheward D; Joag V; Yegorov S; Liebenberg LJ; Yende-Zuma N; Stalker A; Mwatelah RS; Selhorst P; Garrett N; Samsunder N; Balgobin A; Nawaz F; Cicala C; Arthos J; Fauci AS; Anzala AO; Kimani J; Bagaya BS; Kiwanuka N; Williamson C; Kaul R; Passmore JS; Phanuphak N; Ananworanich J; Ansari A; Abdool Karim Q; Abdool Karim SS; McKinnon LR;
    Sci Transl Med; 2018 Jan; 10(425):. PubMed ID: 29367348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered expression of CD4, CD54, CD62L, and CCR5 in primary lymphocytes productively infected with the human immunodeficiency virus.
    Marodon G; Landau NR; Posnett DN
    AIDS Res Hum Retroviruses; 1999 Jan; 15(2):161-71. PubMed ID: 10029248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discordant outcomes following failure of antiretroviral therapy are associated with substantial differences in human immunodeficiency virus-specific cellular immunity.
    Price DA; Scullard G; Oxenius A; Braganza R; Beddows SA; Kazmi S; Clarke JR; Johnson GE; Weber JN; Phillips RE
    J Virol; 2003 May; 77(10):6041-9. PubMed ID: 12719595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kinetics of lymphocyte apoptosis in macaques infected with different simian immunodeficiency viruses or simian/human immunodeficiency hybrid viruses.
    Reinberger S; Spring M; Nisslein T; Stahl-Hennig C; Hunsmann G; Dittmer U
    Clin Immunol; 1999 Jan; 90(1):141-6. PubMed ID: 9884363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gut Homing CD4+ and CD8+ T-Cell Frequencies in HIV Infected Individuals on Antiretroviral Treatment.
    Briceño O; Pinto-Cardoso S; Rodríguez-Bernabe N; Murakami-Ogasawara A; Reyes-Terán G
    PLoS One; 2016; 11(11):e0166496. PubMed ID: 27898686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A simian immunodeficiency virus V3 loop mutant that does not efficiently use CCR5 or common alternative coreceptors is moderately attenuated in vivo.
    Pöhlmann S; Münch J; Aziz S; Reeves JD; Otto C; Leslie GJ; Hofmann H; Puffer BA; Baribaud F; Marzi A; Gramberg T; Chen Z; Stolte N; Haaft PT; Heeney JL; Stahl-Hennig C; Mätz-Rensing K; Schneider T; Doms RW; Kirchhoff F
    Virology; 2007 Apr; 360(2):275-85. PubMed ID: 17126374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short-term antiretroviral therapy fails to reduce the expanded activated CCR5-expressing CD4+ T lymphocyte population or to restore the depleted naive population in chronically HIV-infected individuals with active pulmonary tuberculosis.
    Kabue JP; de Swardt D; de Beer C; Glashoff RH
    AIDS Res Hum Retroviruses; 2013 May; 29(5):769-77. PubMed ID: 23259904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potent antiretroviral therapy of primary human immunodeficiency virus type 1 (HIV-1) infection: partial normalization of T lymphocyte subsets and limited reduction of HIV-1 DNA despite clearance of plasma viremia.
    Zaunders JJ; Cunningham PH; Kelleher AD; Kaufmann GR; Jaramillo AB; Wright R; Smith D; Grey P; Vizzard J; Carr A; Cooper DA
    J Infect Dis; 1999 Aug; 180(2):320-9. PubMed ID: 10395845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Naive T-cell depletion related to infection by X4 human immunodeficiency virus type 1 in poor immunological responders to highly active antiretroviral therapy.
    Delobel P; Nugeyre MT; Cazabat M; Sandres-Sauné K; Pasquier C; Cuzin L; Marchou B; Massip P; Cheynier R; Barré-Sinoussi F; Izopet J; Israël N
    J Virol; 2006 Oct; 80(20):10229-36. PubMed ID: 17005700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Naïve and memory CD4 T cells differ in their susceptibilities to human immunodeficiency virus type 1 infection following CD28 costimulation: implicatip6s for transmission and pathogenesis.
    Riley JL; Levine BL; Craighead N; Francomano T; Kim D; Carroll RG; June CH
    J Virol; 1998 Oct; 72(10):8273-80. PubMed ID: 9733871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.